Intravenous immunoglobulins (IVIg): indications

Recommended indications

• Guillain Barre syndrome (GBS): in adults and children
• Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
• Severe myasthenia gravis (MG)
• Multifocal motor neuropathy (MMN)
• Lambert Eaton myasthenic syndrome (LEMS)
• Dermatomyositis
• Stiff-person syndrome (SPS)
• Myasthenia gravis (MG) exacerbations: not stable disease
• HMGCoA reductase myositis

Conditions with insufficient evidence of benefit

Not recommended indications

References

1. Tavee J, Brannagan 3rd TH, Lenihan MW, Muppidi S, Kellermeyer L, Donofrio PD. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee. Muscle Nerve 2023 (Online ahead of print).

Related checklists

• Intravenous immunoglobulins (IVIg): precautions
• Intravenous immunoglobulins (IVIg): complications